Theses

Date	Thesis
2024-10-21	Steef Konings From administrative data to improved schizophrenia care: on economic modelling of psychotic disorders in a Dutch setting	Prof. Talitha Feenstra Prof. Richard Bruggeman Prof. Jochen Mierau Dr Ellen Visser
2024-10-15	Anne Eudes Jean Baptiste Assessing the Scale of Immunity Gaps Towards Measles Elimination: case studies and epidemiological profile of Nigeria	Prof. Eelko Hak Prof. Elisabeth Sanders Prof. Susan Hahné
2024-03-18	Indrė Trečiokienė Managing High Blood Pressure: Investigating the role of healthcare professionals and drug utilization	Prof. Katja Taxis Prof. Maarten Postma
2024-01-16	Hao Tran Adverse drug reactions in the view of clinical pharmacology: a focus on the female population	Prof. Eelko Hak Dr Henk Groen
2024-01-09	Adrienne Chan International diversity in psychotropic medication use: a pharmacoepidemiological perspective	Prof. Katja Taxis
2023-11-14	Marloes Dankers New medicines in primary care: perspectives and practices of healthcare professionals	Prof. dr ir. Liset van Dijk
2023-11-08	Sajad Emamipour Economic evaluations of precision medicine: case studies in diabetes	Prof. Talitha Feenstra Prof. Maarten Postma
2023-07-04	Laura Schackmann Pharmacy staff-patient interactions in challenging situations: understanding the roots and ways to flourish patient-centered communication	Prof. dr ir. Liset van Dijk
2023-02-20	Monika Oktora Treatment patterns and deprescribing in people with type 2 diabetes	Prof. Eelko Hak
2023-02-14	Naomi Jessurun The metabolization of drugs as a factor in the development of adverse drug reactions	Prof. Eugène van Puijenbroek
2023-01-30	Corine Rollema Perspectives on intranasal administration of corticosteroids: insights into different aspects related to patients, administration techniques and instructions	Prof. Eric van Roon
2022-11-29	Fajri Gafar Optimization of tuberculosis treatment in children and adolescents. Epidemiological and pharmacological approaches	Prof. Katja Taxis
2022-10-31	Johanne Rozema Real-world studies of patients with myelodysplastic syndromes. Survival, treatment and outcomes in a population-based setting	Prof. Eric van Roon
2022-09-19	Tanja Fens-Lazova Perspectives on medication safety and use. Pharmacoeconomics, public policy & practice and pharmacists education	Prof. Maarten Postma Prof. Eugène van Puijenbroek
2022-03-15	Joep Scholl Signal detection in Pharmcovigilance. Time for a new era?	Prof. Eugène van Puijenbroek Prof. Eelko Hak
2021-10-15	Nanno Schreuder Exploring drug safety of radiopharmaceuticals	Prof. Eugène van Puijenbroek Prof. Jos Kosterink
2021-10-11	Berdien Oortgiesen Real-worl studies of patients with mutiple myeloma. Future perspectives on symptom assessment and therapy	Prof. Eric van Roon
2020-11-27	Karin Larmené-Beld Ready to administer parental medication produced by hospital pharmacy	Prof. K. Taxis Prof. M.J. Postma Prof. H.W. Frijlink
2020-10-12	Sylvi Irawati Challenges in the use of preventive cardiovascular medications in Indonesia and The Netherlands	Prof. E. Hak Prof. K. Taxis
2020-10-06	Sofa Dewi Alfian Adherence to antihypertensive or antihyperlipidemic co-medications in diabetis	Prof. E. Hak Prof P. Denig
2020-05-08	Yuanyuan Wang Effectiveness and safety of medicines used in COPD patients: pharmacoepidemiological studies	Prof. E. Hak Prof. M. Boezen
2020-02-24	Ivan Pradipta Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program	Prof. E. Hak Prof. J.W. Alffenaar
2020-02-10	Elfride Sianturi Exploring strategies to optimize pharmacotherapy with antiretrovirals in Papuans living with HIV	Prof. K. Taxis Prof. B. Wilffert
2019-03-22	Heleen van der Meer Describing in older people. Development and evaluation of complex healthcare interventions	Prof. dr K. Taxis Prof. dr L.G. Pont
2018-12-21	Willem van der Veen Information technology and medication safety	Prof. dr K. Taxis Prof. dr P.M.L.A. van den Bemt Prof. dr J.J. de Gier
2018-11-30	Mirjam Simoons Somatic monitoring of patients with mood and anxiety disorders: Problem definition, implementation and further explorations	Prof. dr E.N. van Roon Prof. dr R.A. Schoevers
2018-09-14	Maarten van Wijhe The public health impact of vaccination programmes in the Netherlands	Prof. dr M.J. Postma Prof. dr J. Wallinga
2018-06-29	Ury Arifin Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients	Prof. dr M.J. Postma
2018-06-25	Neily Zakiyah Women's health from a global economic perspective	Prof. dr M.J. Postma
2018-03-23	Leàn Rolfes Patient participation in pharmacovigilance	Prof. dr E.P. van Puijenbroek Prof. dr K. Taxis
2018-03-16	Thang Nuyen Medication use for acute coronary syndrome in Vietnam	Prof. dr K. Taxis Prof. dr B. Wilffert Prof. dr T.T. Pham
2018-01-26	Eva van Doorn Improving influenza prevention. Why universal influenza vaccines are needed	Prof. dr E. Hak Prof. dr A.L.W. Huckriede
2017-08-12	Jurjen van der Schans ADHD and atopic diseases. Pharmacoepidemiological studies	Prof. dr E. Hak Prof. dr P.J. Hoekstra Dr T.W. de Vries
2017-06-02	Jan Peter Yska Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet	Prof. dr E.N. van Roon Prof. dr B. Wilffert
2017-04-24	Nur Aizati Athirah Daud Paving ways for personalizing drug therapy during pregnancy	Prof. dr B. Wilffert Dr J.E.H. Bergman
2017-02-17	Didik Setiawan HPV vaccination in Indonesia: A health-economic & comparative perspective	Prof. dr M.J. Postma Prof. dr B. Wilffert
2016-12-09	Nyashadzaishe Mafirakureva Health economics of blood transfusion in Zimbabwe	Prof. dr M.J. Postma Dr M. van Hulst Dr S. Khoza
2016-12-09	Tonderai Mapako Risk modelling of transfusion transmissible infections	Prof. dr M.J. Postma Dr M. van Hulst
2016-11-18	Renata Šmit Health economics of tick-borne diseases	Prof. dr M.J. Postma Prof. dr K. Poelstra
2016-09-23	Lan Nguyen Health economics of screening for hypertension in Vietnam	Prof. dr M.J. Postma Dr C.C.M. Schuiling-Veninga Dr Nguyen Thi Bach Yen Dr E.P. Wright
2016-09-12	Jovan Mihajlović Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands	Prof. dr M.J. Postma Dr P. Pechlivanglou
2016-06-21	Maryam Darvishian Real-world influenza vaccine effectiveness: New designs and methods to adjust for confounding and bias	Prof. dr E. Hak Prof. dr E.R. van den Heuvel
2016-06-17	Hans-Joerg Fugel Economics of stratified medicine	Prof. dr M.J. Postma Dr M. Nuijten Dr K. Redekop
2016-06-17	Lisette Berm Optimizing treatment with psychotropic agents through precision drug therapy: It is not about the mean	Prof. dr B. Wilffert Prof. dr E. Hak
2016-03-11	Maarten Bijlsma Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology	Prof. dr E. Hak Prof. dr S. Vansteelandt
2016-03-02	Linda de Jong Data quality and methodology in studies on maternal medication use in relation to congenital anomalies	Prof. dr I.M. van Langen Prof. dr L.T.W. de Jong-van den Berg
2016-02-26	Dianna de Vries Statin treatment in type 2 diabetes patients	Prof. dr E. Hak Prof. dr P. Denig Prof. dr M.J. Postma
2016-02-19	Bianca Mulder Medication use during pregnancy and atopic	Prof. dr E. Hak Prof. dr S.S. Jick
2016-01-25	Priscilla Zetstra-van der Woude Data collection on risk factors in pregnancy	Prof. dr L.T.W. de Jong-van den Berg
2015-12-22	Jelena Stevanovic Pharmacoeconomics of cardiovascular disease prevention	Prof. dr M.J. Postma
2015-12-04	Koen Pouwels Self-controlled designs to control confounding	Prof. dr E. Hak
2015-11-17	Jan Wijnia Early detection of mental and motor symptoms in the Wernicke-Korakoff Syndrome	Prof. dr C.I. Mulder Prof. dr A.J.M. Loonen
2015-09-25	Job van Boven Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness	Prof. dr M.J. Postma Prof. dr T. van der Molen
2015-09-16	John Pitman The influence and impact of the U.S. President's Emergency Plan for AIDS Relief (PERFAR) on blood transfusin services in Africa. Case studies from Namibia	Prof. dr M.J. Postma Prof. dr T.S. van der Werf
2015-06-26	Marlies Geurts Integrated Pharmaceutical Care. Cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan	Prof. dr J.J. de Gier Prof. dr J.R.B.J. Brouwers Prof. dr P.A. de Graeff
2015-05-29	Nikolas Kotsopoulos Novel economic perspectives on prevention and treatment: case studies for paediatric, adolescent and adult infectious and chronic diseases	Prof. dr M.J. Postma Dr M. Connolly
2015-05-29	Bo Standaert Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease	Prof. dr M.J. Postma Prof. dr O. Ethgen
2015-05-01	Bart Heeg Modelling chronic diseases for reimbursement purposes	Prof. dr M.J. Postma Prof. dr E. Buskens Prof. dr B.A. van Hout
2014-11-03	Thao Huong Nguyen Medication Safety in Vietnamese Hospitals. A focus on medication errors and safety culture	Prof. dr K. Taxis Prof. dr F.M. Haaijer-Ruskamp Prof. dr J.R.B.J. Brouwers
2014-06-27	Auliya Suwantika Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case	Prof. dr M.J. Postma Dr K. Lestari
2014-05-28	Giedre Gefenaite Newly introduced vaccines. Effectiveness and deterninants of acceptance	Prof. dr E. Hak Prof. dr R.P. Stolk
2014-04-07	Susana Monteiro Driving-impairing Medicines and Traffic Safety. Patients' Perspectives	Prof. dr J.J. de Gier Dr ir. L. van Dijk
2013-10-28	Josien Riphagen-Dalhuisen Influenza vaccination of health care workers	Prof. dr E. Hak
2013-10-25	Fenneke van Hasselt Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions	Prof. dr A.J.M. Loonen Prof. dr M.J. Postma Dr M.J.T. Oud Dr P.F.M. Krabbe
2013-09-13	Mehraj Parouty Inequality Aversion to Posterity: Discounting Human Lives	Prof. dr M.J. Postma
2013-06-28	Hoa Dinh Vu Clinical Pharmacology of Tuberculosis Drugs and Tuberculosis Control in Developing World. The involvement of Private Pharmacy and the individualization of treatment using Dried blood spot	Prof. dr J.R.B.J. Brouwers Prof. dr D.R.A. Uges Prof. dr V.H. Le†/ Prof. dr D.H. Nguyen
2013-06-07	Timothy Broesamle Designing Health Care Services Using Systems Thinking: A Theory, A Method and their Application in the Dutch Community Pharmacy	Prof. dr J.J. de Gier Prof. dr J.J. van der Werf
2013-05-31	Josta de Jong Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands	Prof. dr L.T.W. de Jong-van den Berg Dr T.W. de Vries
2013-04-17	Tjalke Westra Health-economic Modelling of Human Papillomavirus Vaccination	Prof. dr M.J. Postma Prof. dr J.C. Wilschut Prof. dr C.A.H.H. Daemen Prof. dr H.W. Nijman
2013-03-22	Irene Lako Depressive Symptoms in Patients with Schizophrenia. Count symptoms that Count	Prof. dr K. Taxis Prof. dr D. Wiersma
2013-02-25	Mark Rozenbaum Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease	Prof. dr M.J. Postma Prof. dr E. Hak
2013-02-25	Albert Jan van Hoek The Epidemiology and Cost-effectiveness of Vaccination Strategies against Infectious Diseases: a Focus on Varicella Zoster, Pandemic influenza A/H1N1 2009, Streptococcus Pneumonia	Prof. dr M.J. Postma Prof. dr W.J. Edmunds Prof. dr E. Miller
2013-01-11	Peter ter Horst Clinical Pharmacology of Antidepressants During Pregnancy	Prof. dr B. Wilffert Prof. dr L.T.W. de Jong-van den Berg
2012-12-18	Petros Pechlivanoglou Applying and Extending Mixed-effects Models in Health Economics and Outcomes Research	Prof. dr M.J. Postma Prof. dr J.E. Wieringa
2012-11-16	Ineke Crijns Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes	Prof. dr L.T.W. de Jong-van den Berg
2012-10-10	Janna Munster Q Fever During Pregnancy. Lessons From the Dutch Epidemic	Prof. dr E. Hak Prof. dr J.G. Aarnoudse
2012-06-04	Linda Harmark Web-based intensive monitoring : a patient based pharmacovigilance tool	Prof. dr A.C. van Grootheest Prof. dr J.J. de Gier
2012-03-16	Stefan Vegter The value of personalized approaches to improve pharmacotherapy in renal disease	Prof. dr M.J. Postma Prof. dr G. Navis
2012-02-24	Silvia Ravera Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication	Prof. dr J.J. de Gier Prof. dr. L.T.W de Jong-van den Berg
2012-01-27	Hong Anh Thi Tu Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam	Prof. dr M.J. Postma
2011-12-09	Janneke Boersma-Jentink Risk assessment of antiepileptic drugs in pregnancy	Prof. dr L.T.W. de Jong-van den Berg Prof. dr H. Dolk
2011-11-18	Florence van Hunsel The contribution of direct patient reporting to pharmacovigilance	Prof. dr A.C. van Grootheest Prof. dr L.T.W. de Jong-van den Berg
2011-02-04	Evert Jan Mookhoek Patterns of somatic disease in residential psychiatric patients : surveys of dyspepsia, diabetes and skin disease	Prof. dr A.J.M. Loonen Prof. dr J.R.B.J. Brouwers
2011-02-04	Anna Krabbe Lugner Cost-effectiveness of controlling infectious diseases from a public health perspective	Prof. dr M.J. Postma Dr J. Wallinga
2010-10-08	Michiel Duyvendak Pharmaceutical care by clinical pharmacists in patients with musculoskeletal disease	Prof. dr J.R.B.J. Brouwers
2010-04-16	Mark Connolly The Economics of assisted reproduction. Costs and consequences of fertility treatments	Prof. dr M.J. Postma Prof. dr W. Ledger
2010-01-11	Marian Bakker The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy	Prof. dr C.H.C.M. Buijs Prof. dr L.T.W. de Jong-van den Berg
2010-01-08	Susanne Schorr Drug safety in patients with psychotic disorders	Prof. dr K. Taxis Prof. dr J.R.B.J. Brouwers
2010-01-08	Robin de Vries Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making	Prof. dr M.J. Postma Prof. dr L.T.W. de Jong-van den Berg
2009-11-09	Asmar Al Hadithy Pharmacogenetics of Antipsychotic-Induced Parkinsonism and Tardive Dyskenesia: a Focus on African-Caribbeans and Slavonic Caucasians	Prof. dr J.R.B.J. Brouwers Prof. dr A.J.M. Loonen
2009-06-26	Maarten Beinema The optimization of coumarin anticoagulant therapy: Pharmacogenetics and computer assisted dose finding	Prof. dr J.R.B.J. Brouwers Prof. dr J. v.d. Meer
2009-06-12	Cornelis Boersma Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings	Prof. dr M.J. Postma Prof. dr L.T.W. de Jong-van den Berg Prof. dr P.E. de Jong
2009-05-11	Gijs Hubben Cost-effectiveness of infectious disease interventions : combining economic modelling and web technology to support decision making	Prof. dr M.J. Postma
2009-03-20	Fokaline Vroom Drug use in pregnancy. Exploring the field of DMARDs in pregnancy	Prof. dr L.T.W. de Jong-van den Berg Prof. dr J.R.B.J. Brouwers Prof. dr M.A.F.J. van de Laar
2008-11-28	Mark Reinders Practice research in the field of gout. Clinical pharmacology of antihyperuricemic drugs	Prof. dr J.R.B.J. Brouwers Prof. dr M.A.F.J. v.d. Laar
2008-11-14	Tjalling de Vries Improving care in paediatric asthma: patients, prescriptions, pharmacovigilance, pathogens, and particles	Prof. dr L.T.W. de Jong-van den Berg Prof. dr E.J. Duiverman
2008-10-17	Beitske Smink Benzodiazepines and traffic safety. Forensic, analytical-toxicological and epidemiological aspects of driving under the influence of benzodiazepines	Prof. dr D.R.A. Uges Prof. dr A.C.G. Egberts Prof. dr J.J. de Gier
2006-12-08	Willemijn Meijer Drug safety in pregnancy. Studying and communicating teratogenic risks	Prof. dr L.T.W. de Jong-van den Berg Prof. dr J.R.B.J. Brouwers
2006-10-02	Adrianne Faber Stimulant treatment in children: a Dutch perspective	Prof. dr L.T.W. de Jong-van den Berg
2006-09-15	Jarir Atthobari Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects	Prof. dr L.T.W. de Jong-van den Berg Prof. dr P.E. de Jong
2006-06-30	Rogier Klok Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection	Prof. dr J.R.B.J. Brouwers Prof. dr M.J. Postma
2005-05-11	Frank Jansman Chemotherapy for patients with colorectal Cancer	Prof. dr J.R.B.J. Brouwers Prof. dr D.Th. Sleijfer
2005-03-11	Eric van Roon Practice research in the field of rheumatoid arthritis	Prof. dr J.R.B.J. Brouwers Prof. dr M.A.F.J. van de Laar
2004-12-17	Ada Stuurman-Bieze Interventions on the principle of Pulmonary Medication Profiles	Prof. dr L.T.W. de Jong-van den Berg Dr Th.F.J. Tromp
2004-11-19	Andrea Tramarin The changing economic burden of HIV/AIDS in Italy	Prof. dr J.R.B.J. Brouwers Dr M.J. Postma
2004-01-09	Jasper Bos Pharmacoeconomics in infectious disease. The evaluation of prevention programmes	Prof. dr L.T.W. de Jong-van den Berg Dr M.J. Postma
2003-12-01	Vera Deneer Episodic tretment and prevention of paroxysmal atrial fibrilation: studies on flecainide and sotalol	Prof. dr J.R.B.J. Brouwers Prof. dr J.H. Kingma
2003-11-18	Kees van Grootheest Improving Pharmacovigilance and the Role of the Pharmacist	Prof. dr L.T.W. de Jong-van den Berg Dr E.P. van Puijenbroek
2003-10-03	Eric Schirm Drug Exposure from conception till adulthood	Prof. dr L.T.W. de Jong-van den Berg Dr H. Tobi
2003-10-03	Claudia Rijcken Pharmacy Data as a Tool for assessing Antypsychotic Drug Use	Prof. dr L.T.W. de Jong-van den Berg
2003-01-31	Taco Monster Assessing drug influences on urinary albumin excretion	Prof. dr L.T.W. de Jong-van den Berg Prof. dr P.E. de Jong Dr H. Tobi
2002-06-07	Karen van Dijk Pharmacotherapy in frail elderly	Prof. dr L.T.W. de Jong-van den Berg Prof. J.R.B.J. Brouwers
2002-02-22	Patricia van den Bemt Drug safety in hospitalised patients	Prof. dr J.R.B.J. Brouwers Prof. dr A.C.G. Egberts
2001-11-10	Nicolien Wieringa Connecting pre-marketing clinical research and medical practice: the case of the cardiovascular drugs	Prof. dr R. Vos Prof. dr P.A. de Graeff
2001-06-18	Hermien de Walle Awareness and use of folic acid in the Netherlands: from science to practice	Prof. dr C.H.C.M. Buys Prof. dr L.T.W. de Jong-van den Berg
2001-05-04	Roel Fijn Managing Rational Pharmacotherapy in Hospitals: what about drug formularies and pharmacotherapeutic guidelines?	Prof. dr L.T.W. de Jong-van den Berg Prof. dr J.R.B.J. Brouwers
2001-01-19	Marc Weeber Literature-based Discovery in Biomedicine	Prof. dr R. Vos Prof. dr L.T.W. de Jong-van den Berg
2000-06-21	Jennita Reefhuis The Use of Birth Defect Registries for Etiological Research	Prof. dr C.H.C.M. Buys Prof. dr L.T.W. de Jong-van den Berg
2000-01-28	Foppe van Mil Pharmaceutical care, the future of pharmacy	Prof. dr Th.F.J. Tromp Prof. dr L.T.W. de Jong-van den Berg Prof. dr J. McElnay
1998-10-16	Corinne de Vries Collaboration in healthcare, the tango to drug safety	Prof. dr L.T.W. de Jong-van den Berg Prof. dr Th.F.J. Tromp
1998-01-30	Floor Rikken Adverse Drug Reactions in a Different Context; a scientometric approach towards adverse drug reactions as a trigger for the development of new drugs	Prof. dr R. Vos Prof. dr D.K.F. Meijer Prof. dr W. van Rossum
1995-09-22	Anke van Trigt Making News about Medicines	Prof. dr Th.F.J. Tromp Prof. dr M.N.G. Dukes Prof. dr F.M. Haaijer-Ruskamp Dr L.T.W. de Jong-van den Berg
1995-07-07	Miriam Sturkenboom A Field-oriented Postmarketing Surveillance Study on the Teratogen Acitretin	Prof. dr H. Wesseling Prof. dr D.K.F. Meijer Dr L.T.W. de Jong-van den Berg
1992-04-29	Lolkje de Jong-van den Berg Drug Utilization Studies in Pregnancy; what can they contribute to safety assessment?	Prof. dr M.N.G. Dukes Prof. dr H. Wesseling
1989-12-11	Rein Vos Drugs Looking for Diseases; a descriptive model for the process of innovative drug research with special reference to the development of beta blockers and the calcium antagonists	Prof. dr D.K.F. Meijer Prof. dr A.J. Dunning Prof. dr T.A.F. Kuipers Dr H.W.H.J. Bodewitz

Laatst gewijzigd:

04 november 2024 11:07